CellCentric

CellCentric is a clinical stage biotech company focused on the development of a p300/CBP inhibitor to treat specific cancer types, notably multiple myeloma. The company is developing its oral drug, inobrodib.
  • Inobrodib - oral p300/CBP small molecule inhibitor
  • Clinical trials for multiple myeloma and other cancers
Size
Small
Phone
N/A
Website
cellcentric.com
Email
N/A
Locations
Chesterford Research Park, CB10 1XL
01799531130
Digital Popularity
Social Media
Company Details
CellCentric is operated by Cellcentric Limited and is a Active company incorporated on 30 October 2003 with the registered office located in Saffron Walden, Essex. Cellcentric Limited was registered 22 years ago.
Status
Active
Size
Unreported
Directors
9
Age
22 years old
Employees
19
Turnover
Unreported
Total Assets
£41.05M
Cash in Bank
£38.42M
Total Liabilities
-£3.33M
Dr William Henry Lewarne West
Director • British • Lives in UK • Born in Jul 1968
Thea Sarah Stanway
Director • Accountant • British • Lives in England • Born in May 1961
Dr Jasper Bos
Director • None • Dutch • Lives in Netherlands • Born in Jan 1975
Dr Neil Anthony Pegg
Director • Research Director • British • Lives in UK • Born in Oct 1962
Prof Andrew Mark Hughes
Director • Non Exec Director • British • Lives in England • Born in Apr 1964
Dr Irena Melnikova
Director • American • Lives in United States • Born in Aug 1967
More information on Cellcentric Limited
Teams
All
25
Management
15
Research
10
Healthcare
10
Finance
3
Other
3
Naseer Qayum
Chief Strategy Officer • Joined Jan 2025
Tim Fell
Chief Operating Officer
Debbie Haynes
Chief Operating Officer • Joined Jan 2022
Kgosi Tsholetsane
Compliance Manager • Joined Nov 2021
Jessica Verlinden
Finance Manager • Joined Sep 2021
Jonathan Cummins
CMC Director • Joined Nov 2023
Thea Stanway
Finance Director
Anthony Rowen-Brown
Scientific Director • Joined Jun 2011
Steven Salomon
Clinical Trials Manager • Joined Mar 2020
Naseer Qayum
Chief Strategy Officer • Joined Jan 2025
Tim Fell
Chief Operating Officer
Debbie Haynes
Chief Operating Officer • Joined Jan 2022
Kgosi Tsholetsane
Compliance Manager • Joined Nov 2021
Jessica Verlinden
Finance Manager • Joined Sep 2021
Jonathan Cummins
CMC Director • Joined Nov 2023
Thea Stanway
Finance Director
Anthony Rowen-Brown
Scientific Director • Joined Jun 2011
Steven Salomon
Clinical Trials Manager • Joined Mar 2020
Anthony Rowen-Brown
Scientific Director • Joined Jun 2011
Steven Salomon
Clinical Trials Manager • Joined Mar 2020
Ruth Tysoe
Contract Clinical Research Associate • Joined Apr 2019
Kate Fisher
Clinical Trials Manager • Joined Mar 2021
Vlad Melnyk
Clinical Trial Manager • Joined Mar 2025
Fay Ashby
Senior Clinical Trials Manager • Joined Jul 2020
Delyth Carnes
Senior Clinical Trials Manager • Joined Feb 2020
Tracy Wood
Senior Clinical Trials Manager • Joined Oct 2021
Elaine Gilmore
Clinical Research Associate
Gail Millward
Contract Clinical Research Associate • Joined Jul 2020
Steven Salomon
Clinical Trials Manager • Joined Mar 2020
Ruth Tysoe
Contract Clinical Research Associate • Joined Apr 2019
Kate Fisher
Clinical Trials Manager • Joined Mar 2021
Vlad Melnyk
Clinical Trial Manager • Joined Mar 2025
Fay Ashby
Senior Clinical Trials Manager • Joined Jul 2020
Delyth Carnes
Senior Clinical Trials Manager • Joined Feb 2020
Tracy Wood
Senior Clinical Trials Manager • Joined Oct 2021
Carrie Walker
Clinical Administrator • Joined Jan 2020
Elaine Gilmore
Clinical Research Associate
Gail Millward
Contract Clinical Research Associate • Joined Jul 2020
Jessica Verlinden
Finance Manager • Joined Sep 2021
Thea Stanway
Finance Director
Neha Sundar
CTA • Joined Mar 2025
Jacob, Valeria
Clinical Operation Deputy Director • Joined Jan 2025
Kris Frese
Director Of Cancer Biology • Joined Apr 2022
View 25 members